Correction to: Nature Communications https://doi.org/10.1038/s41467-023-38887-7, published online 09 June 2023
This Article omits a declaration from the Competing Interests statement, which should have included the following: ‘A patent “Inhibitors of ACK1/TNK2 Tyrosine Kinase” (patent no. 9,850,216; 10,017,478 and 10,336,734) covers (R)-9b compound. NPM and KM are named as inventors. These patents have been licensed by TechnoGenesys Inc. KM and NPM are co-founders of TechnoGenesys Inc., own stocks, and serve as consultants for TechnoGenesys Inc. The other authors declare no potential conflicts of interest.’
These errors have now been corrected in either the PDF or HTML versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Nguyen, T., Sridaran, D., Chouhan, S. et al. Author Correction: Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer. Nat Commun 14, 6022 (2023). https://doi.org/10.1038/s41467-023-41810-9
Published:
DOI: https://doi.org/10.1038/s41467-023-41810-9
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
